Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A Phase III Multi-National, Multi-Centre, Open Label, 52 Week Safety Study to Assess the Safety of Chronic Therapy With the Humanised AntipTNF PEG Conjugate CDP870 400 mg sc, Dosed 4 weekly to Week 48, in the Treatment of Patients With Active Crohns
De Villiers, Willem
(PI)
Internal Medicine
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
1/15/04
→
12/31/06
View all
View less